The White House Coronavirus Task Force warned in a report this week that the rapid increase in cases this winter may be due to a domestic mutation of the virus that differs from the British mutation.
The working group wrote in its weekly report: “The number of such autumn and winter dresses is almost twice the number of spring and summer dresses.”
The report points out: “This acceleration indicates that in addition to the British variants, American variants may also develop here, and the British variants have spread in our communities, and the possibility of transmission may increase by 50%.”
“Active mitigation measures must be used to match more aggressive viruses; if there is no unified implementation of effective masks (two or three layers and very fit) and strict social isolation, as these variants spread and spread, epidemics It may deteriorate quickly.”
The report does not say that there is conclusive evidence that there is a new strain of the virus, but the rapid increase in cases may indicate that there is a more contagious virus in the United States. The UK has received a new, more contagious strain that has been found in the United States and has been found in several states in the United States.
When asked about the report, former Food and Drug Administration Director Scott Gottlieb said on CNBC on Friday: “This is not actually another mutation that we found here in the United States.
He added: “To a large extent, pattern recognition is where we fit the curve to the top of the British curve. Now what is happening here in the United States looks a lot like what happened in the UK.”
So far, this strain of the British virus is considered more contagious, but not lethal. Although research is still in progress, it is also believed that it is not resistant to vaccines.
In the past few weeks, due to the country’s efforts to control the pandemic, the United States has been regularly recording new records, recording the daily number of infections and deaths from the virus.
Johns Hopkins University (Johns Hopkins University) reported that there were 4,085 coronavirus deaths in the United States on Thursday, the first time that the country has more than 4,000 deaths in a day.
As officials tried to determine who should get the vaccine first and how to do it quickly without wasting a dose, officials tried to prioritize the injection of vaccines, which hurt the launch of Pfizer and Moderna’s approved vaccines.
According to data from the Centers for Disease Control and Prevention (CDC), of the approximately 21 million vaccine doses that have been distributed so far, 6 million doses have been administered. The Trump administration is encouraging states to expand the types of people eligible for vaccination to speed up the process and ensure that strict standards do not slow it down.
In its report this week, the task force urged states not to delay vaccinations for people over 65 or those at high risk of serious complications from the virus.
The report states: “Information transmission must focus on active testing of people under 40 to prevent asymptomatic silence from spreading to their family members, and calls for immediate action and rapid injection of monoclonal antibodies to people at risk of serious diseases. “Every hospital should immediately set up an outpatient infusion station to save lives.”
When asked about last Friday’s report, the CDC stated that there is a “high probability” that there are variants in the United States, but it will take time to determine whether there is a single variant like the United Kingdom that has contributed to this surge. . So far, the variant has been determined.
A CDC spokesperson said: “Based on the scientific understanding of the virus, it is very likely that many variants will evolve at the same time on a global scale.” “In addition, in the United States, there is likely to be a variant; however, it can [take] It takes weeks or months to determine whether there is a single variant of the virus that causes COVID-19, which has contributed to the surge in the United States, similar to the surge in the United Kingdom. “
The spokesperson added: “Researchers have been monitoring strains in the United States since the beginning of the pandemic, including 5,700 samples collected in November and December.” “So far, researchers and analysis of the US Centers for Disease Control and Prevention None of the personnel saw a specific variant in the United States, just like B.1.1.7 in the United Kingdom or B.1.351 in South Africa.”